Pulse Biosciences, Inc.

NASDAQ:PLSE

15.19 (USD) • At close November 4, 2024
Bedrijfsnaam Pulse Biosciences, Inc.
Symbool PLSE
Munteenheid USD
Prijs 15.19
Beurswaarde 934,438,673
Dividendpercentage 0%
52-weken bereik 4.571 - 22.69
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Robert W. Duggan
Website https://www.pulsebiosciences.com

An error occurred while fetching data.

Over Pulse Biosciences, Inc.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation

Vergelijkbare Aandelen

Biodesix, Inc. logo

Biodesix, Inc.

BDSX

1.39 USD

Unity Biotechnology, Inc. logo

Unity Biotechnology, Inc.

UBX

1.26 USD

89bio, Inc. logo

89bio, Inc.

ETNB

9.29 USD

Purple Biotech Ltd. logo

Purple Biotech Ltd.

PPBT

2.97 USD

Cryo-Cell International, Inc. logo

Cryo-Cell International, Inc.

CCEL

7.37 USD

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.357 USD

Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc.

CRDF

3.74 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)